Načítá se...
Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor
With the increasing prevalence of living-donor liver transplantation (LDLT), the possible increased recurrence rate of hepatocellular carcinoma (HCC) in LDLT recipients in comparison with deceased-donor liver transplantation (DDLT) recipients has become a matter of debate. The aim of this review is...
Uloženo v:
| Vydáno v: | Hepatobiliary Surg Nutr |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075829/ https://ncbi.nlm.nih.gov/pubmed/27826557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2016.08.03 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|